Review paper
Budget Impact Analysis of Introducing Lisdexamfetamine Dimesylate for the Treatment of Binge Eating Disorder in the United States
Abstract
Lisdexamfetamine dimesylate (LDX) 50 and 70 mg demonstrated efficacy in terms of reduced binge eating days per week in adults with moderate to severe binge eating disorder (BED) in 2 randomized control trials (RCTs). This analysis aimed to determine the budgetary impact of introducing LDX for the treatment of BED in the United States (US). A 1-year budget impact analysis from a US health care payer’s perspective was performed. The patient...
Paper Details
Title
Budget Impact Analysis of Introducing Lisdexamfetamine Dimesylate for the Treatment of Binge Eating Disorder in the United States
Published Date
Nov 1, 2015
Journal
Volume
18
Issue
7
Pages
A408 - A408
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History